The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...

Enhertu is a HER2-directed antibody and topoisomerase inhibitor conjugate. Approval of the new indication was based on data from the phase 3 DESTINY-Breast06 trial (ClinicalTrials.gov Identifier: ...

The agency approved the drug based on data from the DESTINY-Breast06 trial, which included patients who had tumors with very low HER2 expression.

New approval brings the medicine to an earlier treatment setting and a broader patient population.

AstraZeneca AZN and partner Daiichi Sankyo announced that the FDA has approved the supplemental biologics license application ...

Jan. 9, 2025 — Researchers have shown that a test called ORACLE can predict lung cancer survival at the point of diagnosis better than currently used clinical risk factors. This could help ...

Justin Baldoni has sued Blake Lively and her husband Ryan Reynolds, alleging that the Hollywood couple sought to “destroy” him and his career, after hijacking his film, “It Ends With Us.” ...

The actor-director has accused his "It Ends With Us" costar and her husband of hijacking the film and destroying his reputation. He is requesting at least $400 million in damages. Jessica is a ...

Justin Baldoni, 40, is suing Blake Lively, Ryan Reynolds, their publicist Leslie Sloane and Sloane’s p.r. firm Vision PR Inc. over the continued drama of “It Ends With Us.” Baldoni’s ...

"It Ends With Us" actor and director Justin Baldoni has sued his co-star Blake Lively and her husband, "Deadpool" actor Ryan Reynolds, for defamation on Thursday in the latest step in a bitter ...

By Winston Cho A legal showdown continues to erupt over misconduct allegations in the filming of It Ends With Us, with Justin Baldoni suing Blake Lively and her husband, Ryan Reynolds, for ...

This year's inductees include legendary coaches Nick Saban and Urban Meyer, along with the electrifying quarterback Michael Vick, among others. Nick Saban's inclusion in the Hall of Fame comes as ...